BD (NYSE: BDX) received FDA 510(k) clearance for its EnCor EnCompass Breast Biopsy and Tissue Removal System, the medical technology ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE